How can you benefit from new market opportunities in OTC after the shock of covid-19?

All of our countries implemented sanitary measures for stopping the global Covid-19 pandemic: lockdown, social distancing, frequent handwashing, masks…​

These new habits had a direct impact on viral diseases and potentially changed the development of some OTC segments (digestive, respiratory…).

They also offered more space to new OTC markets (food supplementation, immunity).

As experts in global healthcare market research, we – at AplusA - contribute to your market adaptability. We then propose a dual methodology:

1/ Ensuring your OTC products a high level of referencing in retail pharmacies/ drugstores/ health food stores and a dynamic push from pharmacists:

We conduct qualitative in-depth individual pharmacists’ interviews. 

• Getting to know how they behave with respect to the market segment,
• Understanding the evolution of consumers’ demand,
• Identifying the choice criteria for referencing one product instead of another,
• Getting insights into the type of consumers interested as well as potential ones.

2/ Overtaking the obstacles, becoming increasingly consumer-needs oriented for (re)developing sales. 

We build quantitative surveys of a large sample of consumers. 

• Quantifying the evolution of behaviors and consumers’ demand,
• Building the new adoption ladder,
• Analyzing the evolution of choice criteria during this epidemic situation,
• Updating brand image and satisfaction.